Cetus Corp. Warrants to Expire Dec. 13, 1996.EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec. 6, 1996--Chiron Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CHIR CHIR Chiricahua National Monument (US National Park Service) ) announced today that warrants issued to the purchasors of units in the 1986 Cetus Healthcare Limited Partnership II expire Dec. 13, 1996. Warrant holders currently have the right to acquire 180 shares of Chiron common stock (for every two partnership units held) at a strike price of approximately $23.83 per share (an aggregate cost of $4,290). Originally, for every two partnership units purchased (the minimum investment), investors received the right to buy 150 Cetus shares at a strike price of $28.60 per share (for the same aggregate cost of $4,290). As a result of Chiron's merger with Cetus in 1991, warrant holders received the right to purchase Chiron shares in lieu of Cetus shares. To exercise warrants, holders must contact their stock broker. Alternatively, holders may send the warrant certificate with a brief letter of instruction and a check payable to "CHIRON CORPORATION Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents. " to: Continental Stock Transfer & Trust Co. Exercises, including checks, warrant certificates, and instructions must be received by Continental Stock Transfer & Trust Co. no later than 5 p.m. pacific time on Dec. 13, 1996. For questions regarding the warrants, holders may contact: Continental Stock Transfer & Trust Co. 2 Broadway - 19th Floor, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY 10004 Toll-free phone number 800/509-5586 Chiron Corp. is a science-driven healthcare company that combines diagnostic, vaccine and therapeutic strategies for controlling disease. Chiron participates in four global healthcare markets: diagnostics, including immunodiagnostics, critical care diagnostics and new quantitative probe tests; therapeutics, with an emphasis on oncology and infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. ; pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. and adult vaccines; and ophthalmic surgical products for the correction of vision. Chiron also has research programs underway in gene therapy, combinatorial chemistry, cancer, infectious and cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease and critical care through its Chiron Technologies business unit. CONTACT: Chiron Corp., Emeryville Greg Froese, 510/601-2790 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion